New Key Statistics Module, Z-Score and F-Score
NAS:LGND Key Ratios
Market Cap $ M | 2,295.22 |
Enterprise Value $ M | 2,082.93 |
P/E(ttm) | 48.39 |
PE Ratio without NRI | 22.13 |
Forward PE Ratio | 20.15 |
Price/Book | 2.71 |
Price/Sales | 14.43 |
Price/Free Cash Flow | 394.38 |
Price/Owner Earnings | 43.85 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 152.00 |
EPS (TTM) $ | 2.51 |
Beneish M-Score | -2.77 |
10-y EBITDA Growth Rate % | 25.40 |
5-y EBITDA Growth Rate % | -21.10 |
y-y EBITDA Growth Rate % | -15.10 |
EV-to-EBIT | 34.09 |
EV-to-EBITDA | 21.69 |
PEG | -- |
Shares Outstanding M | 18.90 |
Net Margin (%) | 29.68 |
Operating Margin % | 11.79 |
Pre-tax Margin (%) | 38.59 |
Quick Ratio | 11.95 |
Current Ratio | 12.49 |
ROA % (ttm) | 5.27 |
ROE % (ttm) | 5.97 |
ROIC % (ttm) | 2.22 |
Dividend Yield % | -- |
Altman Z-Score | 13.62 |
LGND Number of Guru Trades
LGND Volume of Guru Trades
Gurus Latest Trades with NAS:LGND
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:LGND is held by these investors
Total 2
Ligand Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:LGND
Total 0- 1